Peadar Tóibín (Meath West, Aontú)
Link to this: Individually | In context | Oireachtas source

181. To ask the Minister for Health the work or efforts his Department is undertaking to reduce and eliminate the differential in breast cancer survival rates in the public versus the private health system. [50793/21]

Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

The Department of Health is not aware of any recent report in regard to a differential in survival rates for breast cancer between patients who are diagnosed and treated in the public system and those diagnosed and treated in the private system.

NCRI data shows that five-year net survival for breast cancer improved markedly from an average of 70% for diagnosis period 1994-1999, to 85% for 2011-2015. This period predates the commencement of the National Cancer Strategy 2017-2026. Further improvements in breast cancer survival rates are to be expected over the lifetime of the Strategy.

As part of Budget 2021, an extra €20m has been allocated for the continued implementation of the National Cancer Strategy this year. Additional funding of €12m has also been allocated in 2021 for the restoration of cancer services in the context of the Covid-19 pandemic. This funding is being used to support hospitals in addressing backlogs, extending clinic times, providing additional clinics, increasing diagnostic capacity and providing locum/temporary support.

The NCCP is continuing to closely monitor trends in numbers coming forward to diagnostic services, and the level of attendances for appointments for treatment.  An important message to everyone now is that, if you have any concerns about cancer, please go to your GP who will arrange appropriate follow-up care. Our cancer diagnostic and treatment services are open, and our healthcare staff will provide any necessary care.

I have now secured a further €20m in Budget 2022 to progress the delivery of the National Cancer Strategy and this will have a significant impact on access to cancer diagnostics, treatment and support to patients across their cancer journey.